Cost-effectiveness of apixaban for prevention of venous thromboembolic events in patients after gynecologic cancer surgery
Amanda Glickman, Alyse Brennecke, Anna Tayebnejad, Koji Matsuo, Saketh R. Guntupalli, Jeanelle Sheeder
Topics & Concepts
MedicineApixabanCost effectivenessPulmonary embolismVenous thrombosisClinical trialIntensive care medicineSurgeryEmergency medicineInternal medicineThrombosisRivaroxabanWarfarinRisk analysis (engineering)Atrial fibrillationVenous Thromboembolism Diagnosis and ManagementHeparin-Induced Thrombocytopenia and ThrombosisBlood Coagulation and Thrombosis Mechanisms